We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Becton Dickinson and Company | NYSE:BDX | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 233.44 | 3 | 14:19:24 |
From Apr 2021 to Apr 2024
By Colin Kellaher
Becton Dickinson & Co. on Tuesday said it plans to invest $200 million in a new manufacturing plan in Spain to support the continued growth of its prefilled drug-delivery business.
The Franklin Lakes, N.J., medical-technology company said the new plant, which would produce drug-delivery devices, would employ 150 people in 2024 and up to 600 when full operations start in 2030.
Becton Dickinson said it plans to begin construction of the new plant, located in the city of Zaragoza in the Aragon region of Spain, in late 2021.
The plant, which would be the company's fourth manufacturing facility in Spain, would initially encompass about 86,000 square feet but would grow to roughly 323,000 square feet by 2020, the company said.
Becton Dickinson said the new plant would be a fully digital site and would meet high sustainability and eco-efficiency standards.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
May 18, 2021 06:32 ET (10:32 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Becton Dickinson Chart |
1 Month Becton Dickinson Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
